Focus on Innuvair<sup>®</sup> Inhaler for Asthma

  • Jacky Van Schoor Amayeza Information Centre
Keywords: Innuvair®, asthma


The long-term goals of asthma management are to achieve good symptom control, to maintain normal activity levels and to minimise future risk of exacerbations, fixed airflow limitation and side-effects of treatment.1 The 2017 Global Initiative for Asthma (GINA) guidelines recommend that treatment with regular daily low-dose inhaled corticosteroids (ICS) is highly effective in reducing asthma symptoms and in reducing the risk of asthma-related exacerbations.1 For patients with persistent symptoms and/or exacerbations despite low-dose ICS, the preferred step-up treatment (Step 3) is combination low-dose ICS/long-acting beta2-agonist (LABA) therapy.1

Author Biography

Jacky Van Schoor, Amayeza Information Centre
Amayeza Information Centre
Product Focus